Systeme und Verfahren zur Charakterisierung von Mutationen
Anmelder: Tempus AI, Inc. 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4797268
- Anmeldetag
- 24. Februar 2026
- Veröffentlichung
- 26. August 2026
- Rechtsraum
- EP
- IPC
- G16B20/20
Abstract
Systems and methods for characterizing a mutation include obtaining reference sequence reads mapping to a genomic location of the mutation from a first sequencing reaction using a reference sample of a subject, and obtaining tumor sequence reads mapping to the genomic location of the mutation from a second sequencing reaction using a solid tumor sample of the subject. A reference base fraction of the mutation is determined using the reference sequence reads. A germline expectation of the mutation is determined using a tumor purity of the solid tumor sample, the major and the minor copy number at the genomic location of the mutation derived from tumor sequence reads. The reference base fraction and the germline expectation of the mutation are inputted into a model thereby obtaining, as output from the model, a determination of whether the mutation is a clonal hematopoiesis of indeterminate potential mutation or a germline mutation.
Anmelder
- Firma
- Tempus AI, Inc.
- Land
- 🇺🇸 USA
Fachgebiete
Die GRUND Intellectual Property Group in München ist auf Patent-, Marken- und Designrecht spezialisiert, mit Schwerpunkt Life Sciences (Biochemie, Neurowissenschaften, Immunologie) sowie Chemie und Pharmazie. Sie vertritt vor Ämtern wie WIPO, EPA, USPTO und DPMA und bietet Lizenzberatung sowie Due Diligence.